More Biosimilars Marketed in Germany, Switzerland Than U.S.
Monthly treatment costs of biosimilars were higher in the United States than corresponding costs in Germany, Switzerland
Mean Length of Preclinical Detectable Phase of Glaucoma >10 Years
Mean length was 10.7 years by the prevalence/incidence method and 10.1 years by the Markov chain Monte Carlo model method
Education Interacts With Genetic Variants to Increase Myopia Risk
Genotype by education interaction identified for five genetic variants, with increased effect for university-level education
FDA: Patients Should Be Cautious When Using Online Pharmacies to Buy Meds
Red flags include pharmacies that do not require a doctor's prescription or have a licensed pharmacist to answer questions
Subretinal Drusenoid Deposits Linked to High-Risk Vascular Disease in AMD
Presence of HRVD can be identified in model including SDD, high-density lipoprotein with accuracy of 78.5 percent
FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’
Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic
Headaches Tied to Higher Risk for Dry Eye Disease
Findings consistent across headache types -- migraine, tension, and cluster
Multidimensional Factors Shaped Physician Stress During Pandemic
Physicians' perceptions of occupational stress at individual level were shaped by stressors within and across four levels
Lipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
Use of lipid-lowering drugs, antidiabetic drugs associated with lower prevalence of any age-related macular degeneration
Age-Related Macular Degeneration Prevalence Remains High
1.49 million people aged 40 years and older are living with late-stage AMD in the United States
